Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 4:30 pm Purchase |
2022-12-31 | 13G | Third Harmonic Bio, Inc. THRD |
Novartis Institutes for BioMedical Research Inc. | 2,642,762 6.500% |
2,642,762 (New Position) |
Filing History |
| 2022-10-31 4:00 pm Unchanged |
2022-10-19 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Novartis Institutes for BioMedical Research Inc. | 698,777 4.700% |
0 (Unchanged) |
Filing History |
| 2022-08-31 4:05 pm Unchanged |
2022-08-08 | 13G | Pliant Therapeutics, Inc. PLRX |
Novartis Institutes for BioMedical Research Inc. | 2,153,526 4.400% |
0 (Unchanged) |
Filing History |
| 2021-02-08 5:24 pm Unchanged |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
Novartis Institutes for BioMedical Research Inc. | 3,948,482 9.710% |
0 (Unchanged) |
Filing History |
| 2021-02-05 5:17 pm Purchase |
2020-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Novartis Institutes for BioMedical Research Inc. | 698,777 5.500% |
698,777 (New Position) |
Filing History |
| 2021-01-22 4:59 pm Sale |
2021-01-21 | 13D | Intellia Therapeutics, Inc. NTLA |
Novartis Institutes for BioMedical Research Inc. | 2,176,148 3.700% |
-2,176,147 (-50.00%) |
Filing History |
| 2020-08-20 4:30 pm Unchanged |
2020-08-06 | 13D | Intellia Therapeutics, Inc. NTLA |
Novartis Institutes for BioMedical Research Inc. | 4,352,295 7.400% |
0 (Unchanged) |
Filing History |
| 2020-06-15 4:40 pm Purchase |
2020-06-05 | 13G | Pliant Therapeutics, Inc. PLRX |
Novartis Institutes for BioMedical Research Inc. | 2,153,526 6.100% |
2,153,526 (New Position) |
Filing History |